NSIM
ALBO

North Star Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

North Star Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-33
Closed -$1K – 1126
2017
Q2 		$1K Hold
33
– – ﹤0.01% 1056
2017
Q1 		$1K Hold
33
– – ﹤0.01% 1030
2016
Q4 		$1K Buy
+33
New +$685 ﹤0.01% 933
2013
Q3 		– Sell
-333
Closed -$42K – 286
2013
Q2 		$42K Buy
+333
New +$34.6K 0.01% 275

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

North Star Investment Management's ALBO Position: Q3 2017 in Review

North Star Investment Management sold out of Albireo Pharma Inc (ALBO) in Q3 2017, closing a stake of 33 shares — an estimated $1K sold.

North Star Investment Management first reported a position in ALBO in Q2 2013 and held it in 4 quarters. The position peaked at $42K in Q2 2013. 22 funds tracked by Wall St. Rank hold ALBO as of Q3 2017.

  • North Star Investment Management reported no remaining Albireo Pharma Inc position as of Q3 2017 after selling out during the quarter.
  • North Star Investment Management sold 33 Albireo Pharma Inc shares in Q3 2017, an estimated $1K.
  • North Star Investment Management first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 4 quarters.
  • North Star Investment Management's Albireo Pharma Inc position peaked at $42K in Q2 2013.
  • 22 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2017.

Based on North Star Investment Management's 13F filing for Q3 2017, filed 6 Oct 2017.